Straumann Group

Description

With almost 30 years of documented evidence supporting its clinical use, enamel matrix derivative (Emdogain®) offers effective solutions for promoting periodontal tissue regeneration and improving clinical outcomes in patients with periodontal bony defects. Its handling properties have inspired surgeons to enhance surgical outcomes through minimally invasive flap designs and improved wound stability. In this webinar, Dr. Sun will provide further insights into the application of Emdogain® for periodontal surgical treatment. Learning Objectives: Understand the biologic mechanisms of Emdogain® in promoting periodontal tissue regeneration. Identify clinical indications and appropriate case selection for the use of Emdogain® in periodontal therapy. Demonstrate proficiency in the surgical techniques for the application of Emdogain®.

Groupe cible: Autre

Segments du produit: Biomatériaux